West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

In the United States, the rate of obesity is lower among college graduates compared to those who did not graduate from college. For example, in 2023, around 27 percent of college graduates were obese, while 36 percent of those with some college or technical school were obese. At that time, rates of obesity were highest among those with less than a high school education, at around 37 percent. Income and obesity As with education level, there are also differences in rates of obesity in the United States based on income. Adults in the U.S. with an annual income of 75,000 U.S. dollars or more have the lowest rates of obesity, with around 29 percent of this population obese in 2023. On the other hand, those earning less than 15,000 U.S. dollars per year had the highest rates of obesity at that time, at 37 percent. One reason for this disparity may be a lack of access to fresh food among those earning less, as cheap food in the United States tends to be unhealthier. What is the most obese state? As of 2023, the states with the highest rates of obesity were West Virginia, Mississippi, and Arkansas. At that time, around 41 percent of adults in West Virginia were obese. The states with the lowest rates of obesity were Colorado, Hawaii, and Massachusetts. Still, around a quarter of adults in Colorado were obese in 2023. West Virginia and Mississippi are also the states with the highest rates of obesity among high school students. Children with obesity are more likely to be obese as adults and are at increased risk of health conditions such as asthma, type 2 diabetes, and sleep apnea.

In 2022, over 33 percent of both men and women in the United States reported themselves as obese (BMI over 30), making it the country with the highest percentage of obese adults on this list. Other selected countries on the list with a high prevalence of obesity among adults included the United Kingdom and Australia. Obesity groups in the United States In 2022, Black adults had the highest overweight and obesity rates of any race or ethnicity in the United States. Asians and Native Hawaiians or Pacific Islanders had the lowest rates by far, with roughly 14 percent. In 2021, about 30 percent of people aged 65 and older were obese in the United States. This estimate has been steadily increasing since 2013 when roughly 27 percent of elderly Americans were obese. Leading health problems worldwide Obesity was considered one of 2023’s biggest health problems: 25 percent of adults worldwide stated that obesity was the biggest health issue for people within their country. Around 44 percent of adults stated that mental health was the most significant problem facing their country that year.

In 2023, around ** percent of all adult Hispanics in Texas were obese. In the United States, processed foods are often cheaper than fresh foods, which can impact those with lower income and lead to more weight gain. This statistic depicts the obesity rates for adults in Texas in 2023, by race/ethnicity.

ABSTRACT Objective: To identify the managerial profile and forms of intersectoral articulation in the framework of food and nutrition carried out in Primary Health Care and verify its association with the prevalence of obesity in the three health macro-regions of the State of Paraíba. Methods: Cross-sectional survey carried out in 151 municipalities in Paraíba, nested in a national population-based survey. Variables related to the manager, managerial profile, intersectoral forms of articulation, and obesity rates among adults were evaluated according to data from the Food and Nutrition Surveillance System. Results: All macro-regions presented a mean of adults obesity higher than the national reference for individual over 18 years of age described in the National Health Plan 2020-2023. The presence of the technician responsible for food and nutrition actions was associated with higher rates of obesity. The performance of food and nutrition education actions, and intersectoral practices related to the Food and Nutrition Security sector were associated with lower prevalence of obesity. Conclusion: The effectiveness of the actions cannot be guaranteed by the presence of a specific position for the actions. Food and Nutrition Education actions are recommended to reduce the prevalence of obesity.

In 2023, around ** percent of all adult Hispanics in Florida were obese. Many states with high obesity rates are also prone to low physical activity rates. This statistic depicts the obesity rates for adults in Florida in 2023, by race/ethnicity.

Lower-intensity interventions delivered in primary and community care contacts could provide more equitable and scalable weight management support for postnatal women. This mixed-methods systematic review aimed to explore the effectiveness, implementation, and experiences of lower-intensity weight management support delivered by the non-specialist workforce. We included quantitative and qualitative studies of any design that evaluated a lower-intensity weight management intervention delivered by non-specialist workforce in women up to 5 years post-natal, and where intervention effectiveness (weight-related and/or behavioural outcomes), implementation and/or acceptability were reported. PRISMA guidelines were followed, and the review was prospectively registered on PROSPERO (CRD42022371828). Nine electronic databases were searched to identify literature published between database inception to January 2023. This was supplemented with grey literature searches and citation chaining for all included studies and related reviews (completed June 2023). Screening, data extraction and risk of bias assessments were performed in duplicate. Risk of bias was assessed using the Joanna Briggs Institute appraisal tools. Narrative methods were used to synthesise outcomes. Seven unique studies described in 11 reports were included from the Netherlands (n = 2), and the United Kingdom, Germany, Taiwan, Finland, and the United States (n = 1 each). All studies reported weight-related outcomes; four reported diet; four reported physical activity; four reported intervention implementation and process outcomes; and two reported intervention acceptability and experiences. The longest follow-up was 13-months postnatal. Interventions had mixed effects on weight-related outcomes: three studies reported greater weight reduction and/or lower postnatal weight retention in the intervention group, whereas four found no difference or mixed effects. Most studies reporting physical activity or diet outcomes showed no intervention effect, or mixed effects. Interventions were generally perceived as acceptable by women and care providers, although providers had concerns about translation into routine practice. The main limitations of the review were the limited volume of evidence available, and significant heterogeneity in interventions and outcome reporting which limited meaningful comparisons across studies. There is a need for more intervention studies, including process evaluations, with longer follow-up in the postnatal period to understand the role of primary and community care in supporting women’s weight management. Public Health Wales was the primary funder of this review.

According to Cognitive Market Research, The Global Cholesterol market size is USD 4.5 billion in 2023 and will grow at a compound annual growth rate (CAGR) of 7.80% from 2023 to 2030.

The global cholesterol market will expand at a significant 7.80% CAGR between 2023 and 2030.
Growing elderly populations, expanding awareness of routine cholesterol monitoring, and rising incidence of elevated cholesterol levels are important market growth drivers.
Demand for high-density lipoprotein remains higher in the cholesterol market.
The Animal-derived category held the highest source in cholesterol market share in 2023.
In 2023, North America held the biggest market share for cholesterol. This is due to increased obesity and heart disease in the United States, rising public awareness and organizational and governmental activities, and a growing desire for preventative treatment.

Surge in Obesity in the Populace Provides Viable Market Output

A rise in the prevalence of obesity has resulted in a rise in the demand for goods and services that control cholesterol levels and general cardiovascular health. This presents various opportunities for the cholesterol market to provide viable solutions that cater to the needs of the growing population concerned about their health. The market can offer a range of cholesterol-lowering supplements and nutraceuticals formulated with ingredients like plant sterols, omega-3 fatty acids, soluble fiber, and antioxidants. These products can help individuals manage their cholesterol levels while complementing their diets.

As an illustration, the WHO's 2021 statistics estimate that 38.2 million children under 5 were overweight or obese that year. Children eat more processed meals and junk food, which reduces the body's supply of vitamins and increases their chance of high cholesterol. As a result, there is a greater demand for frequent cholesterol screening, which is expected to fuel market expansion over the coming years.

(Source:www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)

Market Dynamics of Cholesterol

Low Accuracy in Cholesterol Test Kits to Hinder Market Growth

The accuracy of cholesterol test kits is crucial for individual health management and the overall credibility of the cholesterol market. If test kits provide low accuracy, it can lead to misinformation, ineffective management strategies, and a lack of trust among consumers. This can certainly hamper the growth and reputation of the cholesterol market. Inaccurate test results could lead individuals to make incorrect health decisions. They might unnecessarily modify their diet, medication, or lifestyle based on incorrect information, potentially leading to negative health outcomes.

Impact of COVID-19 on the Market for Cholesterol

The COVID-19 pandemic had a detrimental effect on the cholesterol test business since most blood test labs encountered various issues, and most of them were more severely impacted by the pandemic's second wave. Due to mail delays, unreliability, and airline cancellation, samples arriving at test centers and the availability of laboratory equipment and reagents were all delayed. The availability of the laboratory staff was periodically restricted due to infection, quarantine, or relocation within the healthcare institution. Introduction of Cholesterol

Due to the large number of customers concerned about their health, the pharmaceutical sector is growing and innovating, which opens up opportunities for the cholesterol test market. The expansion of the global market for cholesterol is anticipated to be aided by the availability of enhanced healthcare infrastructure, an increase in unmet healthcare demands, a rise in the incidence of cardiovascular disease, and a spike in demand for cholesterol test kits. The need for improved healthcare services, significant government expenditures to improve the healthcare infrastructure, and the expansion of the medical tourism industry in developing economies are all factors that have contributed to the massive growth of the healthcare sector in emerging economies.

For instance, in an article published by Medical News Today in August 2023, the body naturally manufactures cholesterol, but humans also ingest it through meals, including meat, dairy, and poultry. Some people have a history of high cholesterol in their families, and genetic factors could be involved....

This statistic represents the percentage of adults in the United States that had done no physical activity or exercise within the preceding 30 days, in 2023. That year, Mississippi had the highest rate of physical inactivity among U.S. states, with **** percent of adults reporting no physical activity or exercise besides their job. The state of Utah had the lowest rates of physical inactivity at this time. Physical inactivity and obesityPhysical inactivity is an important risk factor in the development of obesity. Similar to physical inactivity rates, Mississippi had the second-highest rates of obesity in 2023 at around ** percent, while Colorado had the lowest rate at around ** percent. Prevalence rates of obesity have grown steadily among U.S. adults over the decade. Activity recommendationsPhysical inactivity not only increases the risk of being overweight or obese, but also raises the risk of developing other diseases such as cardiovascular disease. Due to the increased health risks of inactivity, the U.S. government recommends at least 150 minutes per week of moderate-intensity or 75 minutes per week of vigorous activity for adults. Children are recommended to include 60 or more minutes per day for aerobic, muscle-strengthening, and bone-strengthening activities three times per week.

China is the country with the highest number of diabetics worldwide, with around *** million people suffering from the disease. By the year 2050, it is predicted that China will have around *** million people with diabetes. Death from diabetes Diabetes is one of the leading causes of death worldwide, accounting for **** million deaths in 2021. Diabetes at least doubles one’s chance of dying prematurely, and many places in the world lack appropriate treatment options. The highest number of deaths from diabetes comes from the Western Pacific, where around *** million people died from the disease in 2024. Obesity One of the biggest risk factors for developing diabetes is being overweight or obese. Rates of obesity have increased in recent years in many countries around the world. In the United States, for example, it is estimated that around ** percent of the adult population was obese in 2023, compared to ** percent of the population in 2011.

The death rate due to diabetes mellitus in Canada has fallen since 2000 from **** per 100,000 population to **** deaths per 100,000 population in 2023. Diabetes is the seventh leading cause of death in Canada. In the United States, it was responsible for **** deaths per 100,000 population in 2023. About diabetesDiabetes mellitus is due to an insufficient production of insulin within the pancreas or a lack of response from the body to the insulin that is produced. The most common type of diabetes mellitus is type II diabetes, which accounts for over ** percent of diabetes cases in the United States. Type II diabetes occurs when cells in the body are unresponsive to insulin and may lead to a decrease in insulin production as well. Prevention and costsOne of the greatest problems with type II diabetes is that it can lead to many different complications such as some types of cancer, cardiovascular disease, and even amputations. This type of diabetes is largely associated with overweight and obese populations and those who are physically inactive. It is also considered a preventable disease by maintaining healthy diets and balanced lifestyles. Health care expenditures to treat diabetes in the United States amounted to around ***** billion U.S. dollars as of 2024, while China, a country with a lower diabetes incidence but a much larger population, spent about *** billion U.S. dollars.